Asymptomatic atrial fibrillation in patients treated with BTK inhibitors in hematologic malignancies: a systematic review and metanalysis

Published: 16 June 2026
Author(s): Giuseppe Boriani, Jacopo Francesco Imberti, Annachiara Valenti, Marco Vitolo, Teresa Lopez-Fernandez, Davide Antonio Mei
Issue: July 2026
Section: Original Article
Read on EJIM website

Atrial fibrillation (AF) is a frequent complication of Bruton’s tyrosine kinase inhibitor (BTKi) therapy, yet the proportion of asymptomatic AF events in this setting remains poorly defined.

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More